Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05371340 · ClinicalTrials.gov registry record · NA
Quercetin's Effect on Bone Health and Inflammatory Markers
A NA study, sponsored by Kennesaw State University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT05371340 is a NA study that has completed, run by Kennesaw State University. The registered enrollment target is 33 participants.
The verdict
NCT05371340, a NA study, has completed, sponsored by Kennesaw State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Quercetin is a plant-based flavonoid that is naturally found in many fruits and vegetables, and is considered to be a potent antioxidant with several expected health benefits such as anti-inflammatory effects and bone-conserving properties. Participants will supplement with either Quercetin, or placebo, for 90-days with pre- and post-testing visits.
Interventions
- DIETARY_SUPPLEMENT Quercetin (500 mg)
- OTHER Placebo (500 mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-08-27 |
| Est. Completion | 2020-04-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05371340
The ClinicalTrials.gov registry entry for NCT05371340 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kennesaw State University, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quercetin (500 mg) is the first listed.
NCT05371340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05371340 about?
NCT05371340 is a clinical study titled "Quercetin's Effect on Bone Health and Inflammatory Markers". Quercetin is a plant-based flavonoid that is naturally found in many fruits and vegetables, and is considered to be a potent antioxidant with several expected health benefits such as anti-inflammatory effects and bone-conserving properties. Participants will supplement with either Quercetin, or plac...
What is the current status of trial NCT05371340?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-08-27. Estimated completion is 2020-04-27.
What interventions are being tested in trial NCT05371340?
The interventions under investigation include: Quercetin (500 mg) (DIETARY_SUPPLEMENT), Placebo (500 mg) (OTHER).
Who is sponsoring clinical trial NCT05371340?
This trial is sponsored by Kennesaw State University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.